Physician profile
Miriam Thomas
NPI 1760525257
$538.50
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.26 · 2021: $15.01 · 2022: $86.37 · 2023: $81.22 · 2024: $78.45 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $118.82 | 2025 | Neffy |
| Pfizer INC. | $94.90 | 2019-2025 | |
| Glaxosmithkline, LLC. | $75.22 | 2022-2024 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $62.19 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaqta |
| Sanofi Pasteur INC. | $45.59 | 2019-2024 | |
| Cranial Technologies, INC | $30.10 | 2021-2025 | Doc Band |
| Kaleo, INC. | $26.20 | 2019-2022 | |
| Novo Nordisk INC | $24.56 | 2025 | Wegovy |
| Alk-Abello, INC | $16.86 | 2025 | Neffy, Odactra, Grastek |
| Seqirus USA INC | $15.23 | 2023 | Flucelvax Quadrivalent |
| Aytu Biopharma, INC. | $14.98 | 2022 | |
| Genentech USA, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.